Stockscreener 앱 받기
12.40
1.35%
-0.17
전일 마감가:
$12.57
열려 있는:
$12.58
하루 거래량:
26,006
Relative Volume:
0.50
시가총액:
$272.72M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+3.25%
1개월 성능:
-10.92%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$11.55
$13.24
1주일 범위
$11.50
$13.63
52주 변동 폭
$4.88
$19.58
Aardvark Therapeutics Inc Stock (AARD) Company Profile
명칭
Aardvark Therapeutics Inc
전화
(858) 225-7696
주소
4370 LA JOLLA VILLAGE DRIVE, SAN DIEGO
AARD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AARD
Aardvark Therapeutics Inc
|
12.57 | 272.19M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
377.15 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.51 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
427.60 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
668.59 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
294.76 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Aardvark Therapeutics Inc Stock (AARD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-30 | 개시 | H.C. Wainwright | Buy |
| 2025-03-10 | 개시 | BofA Securities | Buy |
| 2025-03-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-03-10 | 개시 | Morgan Stanley | Overweight |
| 2025-03-10 | 개시 | RBC Capital Mkts | Outperform |
Aardvark Therapeutics Inc 주식(AARD)의 최신 뉴스
Is Aardvark Therapeutics Inc. meeting your algorithmic filter criteriaEquity Performance Forecast Based on AI Models - Newser
Technical signs of recovery in Aardvark Therapeutics Inc.Free Accurate Technical Trend Reversal Picks - Newser
Moving Average Trends for Aardvark Therapeutics Inc. Stock: What They IndicateFree Community Verified Stock Suggestions - Newser
Can machine learning forecast Aardvark Therapeutics Inc. recoveryFree Proven Entry Plan With Low Risk Trade - Newser
Why Aardvark Therapeutics Inc. stock is on top investor watchlistsFree Triple Digit Return Stock Predictions - Newser
Published on: 2025-08-05 19:48:37 - Newser
News impact scoring models applied to Aardvark Therapeutics Inc.Free Fundamental + Technical Hybrid Stock Tips - Newser
Aardvark Therapeutics, Inc.’s (NASDAQ:AARD) Lock-Up Period Set To Expire on August 12th - Defense World
Combining price and volume data for Aardvark Therapeutics Inc.Free Capital Preserving Trade Plan Templates - Newser
Volume spikes in Aardvark Therapeutics Inc. stock – what they meanFree Quick Gain Stock Watch With Indicators - Newser
Why Aardvark Therapeutics Inc. stock attracts strong analyst attentionShort Term Gain Strategy with AI Logic - Newser
What analysts say about Aardvark Therapeutics Inc. stockBuild wealth steadily with smart trading - Jammu Links News
Evaluating Aardvark Therapeutics Inc. with trendline analysisWealth Accumulation Outlook for Safe Investors - Newser
Why is Aardvark Therapeutics Inc. stock attracting strong analyst attentionUnlock daily market insights for better decisions - Jammu Links News
Applying big data sentiment scoring on Aardvark Therapeutics Inc.Risk-Managed Trade Alerts for Consistency - newser.com
What are the latest earnings results for Aardvark Therapeutics Inc.Consistent double returns - Jammu Links News
Risk vs reward if holding onto Aardvark Therapeutics Inc.High Conviction Stock Long-Term Summary - newser.com
Is Aardvark Therapeutics Inc. a good long term investmentInvest smarter with data-backed insights - Jammu Links News
How does Aardvark Therapeutics Inc. compare to its industry peersBuild a portfolio that outperforms the market - Jammu Links News
How does Aardvark Therapeutics Inc. generate profit in a changing economyDiscover investment plans that deliver results - Jammu Links News
What makes Aardvark Therapeutics Inc. stock price move sharplyAchieve breakthrough financial results - Jammu Links News
What are analysts’ price targets for Aardvark Therapeutics Inc. in the next 12 monthsUnmatched profit potential - Jammu Links News
Published on: 2025-08-03 04:04:58 - Jammu Links News
Reversal indicators forming on Aardvark Therapeutics Inc. stockSmart Stock Forecast Using AI Algorithms - Newser
Strategies to average down on Aardvark Therapeutics Inc.Free Risk-Adjusted Picks With Exit Strategy - Newser
Earnings visualization tools for Aardvark Therapeutics Inc.Daily Pick Forecast with Entry Zones - Newser
What’s next for Aardvark Therapeutics Inc. stock priceEarnings Impact and Stock Reaction Analysis - Newser
Sector ETF performance correlation with Aardvark Therapeutics Inc.Breakout Entry Signal Confirmation Tool Used - metal.it
Published on: 2025-07-30 23:36:06 - Newser
Aardvark Therapeutics Inc (AARD) 재무 분석
Aardvark Therapeutics Inc (AARD)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Aardvark Therapeutics Inc 주식 (AARD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Lee Tien-Li | Chief Executive Officer |
Feb 14 '25 |
Buy |
16.00 |
16,542 |
264,672 |
1,496,175 |
| Sun Nelson | Chief Financial Officer |
Feb 14 '25 |
Buy |
16.00 |
10,000 |
160,000 |
99,484 |
| Cormorant Asset Management, LP | Former 10% Owner |
Feb 14 '25 |
Buy |
16.00 |
187,500 |
3,000,000 |
987,689 |
0.53%
0.00%
자본화:
|
볼륨(24시간):